Prosecution Insights
Last updated: October 26, 2026

Joseph G Dauner, USPTO Patent Examiner

Listed by the USPTO as DAUNER, JOSEPH G

Tech Center 1600 • Art Units: 1634 1637 1682 1699

This examiner grants 57% of resolved cases

Analysis

Joseph G. Dauner has 739 resolved cases in Tech Center 1600 and Art Unit 1634. The allowance rate is 57.0%, and the median time to allowance is 1174 days. This large record provides meaningful historical coverage, showing a moderate allowance outcome alongside a prosecution period that is often lengthy.

The interview lift is 35.3%. Applicants may therefore find value in using interviews to clarify technical distinctions and focus subsequent written responses, while still accounting for the examiner's moderate allowance pattern. The leading companies include Thermo Fisher Scientific, Flagship Pioneering, and Toppan Holdings. Kilpatrick Townsend, CASIMIR JONES, and FOLEY & LARDNER are among the listed firms.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

57.0%
Allow Rate
-3.0% vs TC avg
818
Total Applications
+35.3%
Interview Lift
1174
Avg Prosecution Days
Based on 739 resolved cases, 2023–2026

Rejection Statute Breakdown

12.5%
§101 Eligibility
15.8%
§102 Novelty
28.4%
§103 Obviousness
32.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17873788 MULTIPLEXED SPATIAL CAPTURE OF ANALYTES Non-Final OA 10x Genomics, Inc.
18261366 METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA Final Rejection THE JOHNS HOPKINS UNIVERSITY
18026287 HYBRID PROTOCOLS AND BARCODING SCHEMES FOR MULTIPLE SEQUENCING TECHNOLOGIES Final Rejection The Regents of the University of California
18652258 METHOD OF DETECTING TARGET SUBSTANCE Non-Final OA TOPPAN HOLDINGS INC.
18498339 FLAP PROBE AND USE THEREOF Non-Final OA TOPPAN INC.
17595263 DEVICES AND METHODS FOR SAMPLE ANALYSIS Non-Final OA Roche Sequencing Solutions, Inc
18707525 METHOD FOR PREDICTING REACTIVITY TO ANTICANCER DRUGS BY ANALYZING GENOMIC DNA METHYLATION STATUS Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18675633 SYSTEM AND METHOD FOR PREPARATION OF NUCLEOTIDE SOLUTIONS Non-Final OA Life Technologies Corporation
18506885 METHODS AND COMPOSITIONS FOR MULTIPLEX PCR Non-Final OA LIFE TECHNOLOGIES CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Joseph G Dauner's allowance rate?

57.0% of resolved applications examined by Joseph G Dauner were allowed (739 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.

Does an interview help with examiner Joseph G Dauner?

This examiner's interview lift is +35.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Joseph G Dauner take to allow a patent?

Applications allowed by Joseph G Dauner took 1,174 days on average from filing to allowance.

Which art unit does examiner Joseph G Dauner work in?

Joseph G Dauner examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month